The Patent Finder

Brain-Gen Biotech

Also on record
Records under this name other than patents Brain-Gen Biotech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Brain-Gen Biotech

PatentTitleStatus Expires Confidence
US 7,776,817Neuregulins for Prevention and Treatment of Damage from Acute Assault on Vascular and Neuronal Tissue and as Regulators of Neuronal Stem Cell Migration
Lapsed on the fee record
Ended Aug 17, 2022 · High confidence
Lapsed on the fee recordEnded Aug 17, 2022High confidence
US 8,785,369Neuregulins for Prevention and Treatment of Damage from Acute Assault on Vascular and Neuronal Tissue and as Regulators of Neuronal Stem Cell Migration
Lapsed on the fee record
Ended Jul 22, 2022 · Medium confidence
Lapsed on the fee recordEnded Jul 22, 2022Medium confidence
US 8,748,131Chimeric neuregulins and method of making and use thereof
Lapsed on the fee record
Ended Jun 10, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 10, 2022From the USPTO record
US 8,008,249Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
Lapsed on the fee record
Ended Aug 30, 2019 · From the USPTO record
Lapsed on the fee recordEnded Aug 30, 2019From the USPTO record
US 7,973,007Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
Lapsed on the fee record
Ended Jul 5, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jul 5, 2019From the USPTO record
US 8,933,034Chimeric Neuregulins and Method of Making and Use Thereof
Lapsed on the fee record
Ended Jan 13, 2019 · Low confidence
Lapsed on the fee recordEnded Jan 13, 2019Low confidence
US 8,927,483Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration
Lapsed on the fee record
Ended Jan 6, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 6, 2019From the USPTO record
US 8,791,067Composition and Method for Reducing Tissue Damage from Inflammatory Disorder or Pathogenic Infection
Lapsed on the fee record
Ended Jul 29, 2018 · High confidence
Lapsed on the fee recordEnded Jul 29, 2018High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited